Temperature and Salting out Effects on Nicotine Dissolution Kinetics in Saline Solutions

le Chen, Chia-Yu, Papadopoulos, Kyriakos D.
Foilsithe in ACS Omega (2020)

trans-Double Bond-Containing Liposomes as Potential Carriers for Drug Delivery

le Giacometti, Giorgia, Marini, Marina, Papadopoulos, Kyriakos, Ferreri, Carla, Chatgilialoglu, Chryssostomos
Foilsithe in Molecules (2017)

Temperature-Induced Protein Release from Water-in-Oil-in-Water Double Emulsions

le Rojas, Edith C., Staton, Jennifer A., John, Vijay T., Papadopoulos, Kyriakos D.
Foilsithe 2008

Liposomes in Double-Emulsion Globules

le Wang, Qing, Tan, Grace, Lawson, Louise B., John, Vijay T., Papadopoulos, Kyriakos D.
Foilsithe 2010

Anti‐Hu‐Associated Autoimmune Limbic Encephalitis in a Patient with PD‐1 Inhibitor‐Responsive Myxoid Chondrosarcoma

le Papadopoulos, Kyriakos P., Romero, Rebecca S., Gonzalez, Gabriela, Dix, James E., Lowy, Israel, Fury, Matthew
Foilsithe in Oncologist (2017)

Safety and tolerability of quizartinib, a FLT3 inhibitor, in advanced solid tumors: a phase 1 dose-escalation trial

le Papadopoulos, Kyriakos P., Ben-Ami, Eytan, Patnaik, Amita, Trone, Denise, Li, Jianke, Demetri, George D.
Foilsithe in BMC Cancer (2018)

Evaluation of the pharmacokinetic drug interaction potential of tivantinib (ARQ 197) using cocktail probes in patients with advanced solid tumours

le Tachibana, Masaya, Papadopoulos, Kyriakos P., Strickler, John H., Puzanov, Igor, Gajee, Roohi, Wang, Yibin, Zahir, Hamim
Foilsithe in Br J Clin Pharmacol (2017)

Membrane Lipidome Reorganization and Accumulation of Tissue DNA Lesions in Tumor-Bearing Mice: An Exploratory Study

le Krokidis, Marios G., Louka, Maria, Efthimiadou, Eleni K., Zervou, Sevasti-Kiriaki, Papadopoulos, Kyriakos, Hiskia, Anastasia, Ferreri, Carla, Chatgilialoglu, Chryssostomos
Foilsithe in Cancers (Basel) (2019)

Phase I, first-in-human trial of programmed cell death receptor-1 (PD-1) inhibitor, JTX-4014, in adult patients with advanced, refractory, solid tumors

le Papadopoulos, Kyriakos P., Lakhani, Nehal, Falchook, Gerald S., Riley, Gosia, Baeck, Johan, Brown, Karen S., Gordon, Gilad, Le, Lidya, Wang, Judy S.
Foilsithe in Cancer Immunol Immunother (2020)

Assessment of DNA Topoisomerase I Unwinding Activity, Radical Scavenging Capacity, and Inhibition of Breast Cancer Cell Viability of N-alkyl-acridones and N,N′-dialkyl-9,9′-biacrid...

le Krokidis, Marios G., Molphy, Zara, Efthimiadou, Eleni K., Kokoli, Marianna, Argyri, Smaragda-Maria, Dousi, Irini, Masi, Annalisa, Papadopoulos, Kyriakos, Kellett, Andrew, Chatgilialoglu, Chryssostomos
Foilsithe in Biomolecules (2019)

A phase 1 dose escalation and expansion study of Tarextumab (OMP-59R5) in patients with solid tumors

le Smith, David C., Chugh, Rashmi, Patnaik, Amita, Papadopoulos, Kyriakos P., Wang, Min, Kapoun, Ann M., Xu, Lu, Dupont, Jakob, Stagg, Robert J., Tolcher, Anthony
Foilsithe in Invest New Drugs (2018)

Physiologically‐based pharmacokinetic modelling to predict oprozomib CYP3A drug–drug interaction potential in patients with advanced malignancies

le Ou, Ying, Xu, Yang, Gore, Lia, Harvey, R. Donald, Mita, Alain, Papadopoulos, Kyriakos P., Wang, Zhengping, Cutler, Richard E., Pinchasik, Dawn E., Tsimberidou, Apostolia M.
Foilsithe in Br J Clin Pharmacol (2018)

A Phase I study to evaluate the safety and antitumor activity of durvalumab (MEDI4736) in combination with tremelimumab in patients with advanced solid tumors

le Papadopoulos, Kyriakos P, Tsai, Frank, Hamid, Omid, Xiao, Feng, Steele, Keith E, Rebelatto, Marlon C, Robbins, Paul B, Karakunnel, Joyson J, Lai, Dominic W, Mahipal, Amit
Foilsithe in J Immunother Cancer (2015)

Preclinical investigations and a first-in-human phase I trial of M4112, the first dual inhibitor of indoleamine 2,3-dioxygenase 1 and tryptophan 2,3-dioxygenase 2, in patients with...

le Naing, Aung, Eder, Joseph P, Piha-Paul, Sarina A, Gimmi, Claude, Hussey, Elizabeth, Zhang, Sen, Hildebrand, Vera, Hosagrahara, Vinayak, Habermehl, Christina, Moisan, Jacques, Papadopoulos, Kyriakos P
Foilsithe in J Immunother Cancer (2020)

Fixed Dose of Cemiplimab in Patients with Advanced Malignancies Based on Population Pharmacokinetic Analysis

le Paccaly, Anne J., Migden, Michael R., Papadopoulos, Kyriakos P., Yang, Feng, Davis, John D., Rippley, Ronda K., Lowy, Israel, Fury, Matthew G., Stankevich, Elizabeth, Rischin, Danny
Foilsithe in Adv Ther (2021)

Pegilodecakin as monotherapy or in combination with anti‐PD‐1 or tyrosine kinase inhibitor in heavily pretreated patients with advanced renal cell carcinoma: Final results of cohor...

le Tannir, Nizar M., Papadopoulos, Kyriakos P., Wong, Deborah J., Aljumaily, Raid, Hung, Annie, Afable, Manuel, Kim, Jong Seok, Ferry, David, Drakaki, Alexandra, Bendell, Johanna, Naing, Aung
Foilsithe in Int J Cancer (2021)

Phase I Dose-Escalation Study of EZN-2208 (PEG-SN38), a Novel Conjugate of Poly(ethylene) Glycol and SN38, Administered Weekly in Patients With Advanced Cancer

le Patnaik, Amita, Papadopoulos, Kyriakos P., Tolcher, Anthony W., Beeram, Muralidhar, Urien, Saïk, Schaaf, Larry J., Tahiri, Sanaa, Bekaii-Saab, Tanios, Lokiec, François M., Rezaï, Keyvan, Buchbinder, Aby
Foilsithe 2013

A phase I/II study of carfilzomib 2–10-min infusion in patients with advanced solid tumors

le Papadopoulos, Kyriakos P., Burris, Howard A., Gordon, Michael, Lee, Peter, Sausville, Edward A., Rosen, Peter J., Patnaik, Amita, Cutler, Richard E., Wang, Zhengping, Lee, Susan, Jones, Suzanne F., Infante, Jeffery R.
Foilsithe 2013

Phase 1 and pharmacokinetic study of LY3007113, a p38 MAPK inhibitor, in patients with advanced cancer

le Goldman, Jonathan W., Rosen, Lee S., Tolcher, Anthony W., Papadopoulos, Kyriakos, Beeram, Muralidhar, Shi, Peipei, Pitou, Celine, Bell, Robert, Kulanthaivel, Palaniappan, Zhang, Xuekui, Fink, Aaron, Chan, Edward M., Shahir, Ashwin, Farrington, Daphne, Patnaik, Amita
Foilsithe in Invest New Drugs (2017)

Correction to: A phase I study of LY3164530, a bispecific antibody targeting MET and EGFR, in patients with advanced or metastatic cancer

le Patnaik, Amita, Gordon, Michael, Tsai, Frank, Papadopoulos, Kyriakos P., Rasco, Drew, Beeram, Muralidhar, Fu, Siqing, Janku, Filip, Hynes, Scott M., Gundala, Sushma R., Willard, Melinda D., Zhang, Wei, Lin, Aimee Bence, Hong, David
Foilsithe in Cancer Chemother Pharmacol (2018)